Profeta, Justine Carl T.

HRN: 28-75-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2026
CEFUROXIME 750MG (VIAL)
03/25/2026
04/01/2026
IV
770mg
Q8
T/c PCAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: